Losartan dosage
Pro Research Analysisby 
Searched over 200M research papers for "losartan dosage"
Consensus Meter
Losartan Dosage: Clinical Insights and Recommendations
Introduction to Losartan and Its Pharmacokinetics
Losartan is an orally active angiotensin II receptor antagonist used primarily for treating hypertension. It is rapidly absorbed, reaching peak concentrations within 1-2 hours post-administration. Approximately 14% of a losartan dose is converted to its active metabolite, E 3174, which is significantly more potent than the parent compound. The pharmacokinetics of losartan and E 3174 are linear and dose-proportional, with no significant changes observed with repetitive administration.
Recommended Dosage and Administration
Standard Dosage for Adults
The standard recommended dosage of losartan for adults is 50 mg once daily, which can be taken with or without food. The maximum recommended daily dose is 100 mg, which can be administered either as a single dose or split into two doses. This dosage effectively reduces blood pressure and is comparable to other angiotensin-receptor antagonists.
Dosage Adjustments in Special Populations
No dosage adjustment is necessary for patients with mild hepatic impairment or varying degrees of renal insufficiency. However, losartan should be avoided during pregnancy due to the risk of serious fetal toxicity.
Dosage in Pediatric Patients
Hypertensive Children Aged 6-16 Years
In hypertensive children aged 6-16 years, losartan has been shown to reduce blood pressure in a dose-dependent manner. A starting dose of 0.75 mg/kg (up to a maximum of 50 mg) once daily is effective, with dosages up to 1.44 mg/kg (maximum 100 mg) being well tolerated.
Hypertensive Children Aged 6 Months to 6 Years
For younger children aged 6 months to 6 years, losartan dosages ranging from 0.1 to 0.7 mg/kg per day have been studied. Although significant blood pressure reductions were observed, no clear dose-response relationship was established. The maximum dosage in this age group should not exceed 1.4 mg/kg per day.
Efficacy and Safety
Blood Pressure Reduction
Losartan effectively reduces blood pressure in both adults and children. In adults, dosages of 50 to 100 mg once daily have shown significant reductions in systolic and diastolic blood pressure, comparable to other antihypertensive agents like enalapril and atenolol . In children, similar efficacy has been observed with appropriate weight-based dosing.
Renal and Cardiovascular Protection
Losartan has demonstrated significant benefits in reducing the incidence of renal and cardiovascular events. In patients with type 2 diabetes and proteinuria, losartan significantly reduced the incidence of doubling serum creatinine, end-stage renal disease (ESRD), and death. Additionally, losartan has shown beneficial hemodynamic effects in heart failure patients, improving systemic vascular resistance and cardiac index.
Safety and Tolerability
Losartan is generally well tolerated, with a safety profile similar to placebo. Common adverse events include headache, dizziness, and upper respiratory tract infections, but these are infrequent and mild . The drug does not interact significantly with other medications, making it a safe option for patients with multiple comorbidities.
Conclusion
Losartan is a versatile and effective antihypertensive agent suitable for a wide range of patients, including children and those with renal or hepatic impairments. Its favorable pharmacokinetic profile, combined with its efficacy in reducing blood pressure and protecting against renal and cardiovascular events, makes it a valuable option in hypertension management. Proper dosing, tailored to the patient's age and condition, ensures optimal therapeutic outcomes with minimal adverse effects.
Sources and full results
Most relevant research papers on this topic